The power of neuroimaging biomarkers for screening frontotemporal dementia

Human Brain Mapping

Volumn 35, Issue 9, 2014, Pages 4827-4840

  Mcmillan, Corey T ^a   Avants, Brian B ^b   Cook, Philip ^b   Ungar, Lyle ^c   Trojanowski, John Q ^a   Grossman, Murray ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Biomarkers; Classification; DTI; Frontotemporal degeneration; MRI; Statistical power

Indexed keywords

AGED; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CORPUS CALLOSUM; DEGENERATIVE DISEASE; DIFFUSION TENSOR IMAGING; ECHO PLANAR IMAGING; FEMALE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; PREDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY CONTROL; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; VENTROMEDIAL PREFRONTAL CORTEX; BRAIN; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROCEDURES; STATISTICAL MODEL;

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BRAIN; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DIFFUSION TENSOR IMAGING; FEMALE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; GRAY MATTER; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY; TAU PROTEINS;

EID: 84903644222     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22515     Document Type: Article

References (65)

1. Adler DH, Pluta J, Kadivar S, Craige C, Gee JC, Avants BB, Yushkevich PA (2014): Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI. Neuroimage 84:505-523.
2. Alexander DC, Pierpaoli C, Basser PJ, Gee JC (2001): Spatial transformations of diffusion tensor magnetic resonance images. IEEE Trans Med Imaging 20:1131-1139.
3. Ard MC, Edland SD (2011): Power calculations for clinical trials in Alzheimer's disease. J Alzheimers Dis 26 (Suppl 3):369-377.
4. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tröster AI, Vidailhet M, Weiner WJ (2013): Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496-503.
5. Augustinack JC, van der Kouwe AJW, Fischl B (2013): Medial temporal cortices in ex vivo magnetic resonance imaging. J Comp Neurol 521:4177-4188.
6. Avants BB, Epstein CL, Grossman M, Gee JC (2008): Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12:26-41.
7. Avants BB, Cook PA, Ungar L, Gee JC, Grossman M (2010): Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysis. Neuroimage 50:1004-1016.
8. Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC (2011): A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54:2033-2044.
9. Avants B, Dhillon P, Kandel BM, Cook PA, McMillan CT, Grossman M, Gee JC (2012): Eigenanatomy improves detection power for longitudinal cortical change. Med Image Comput Comput Assist Interv 15:206-213.
10. Avants BB, Libon DJ, Rascovsky K, Boller A, McMillan CT, Massimo L, Coslett HB, Chatterjee A, Gross RG, Grossman M (2014): Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population. Neuroimage 84:698-711.
11. Boxer AL, Gold M, Huey E, Gao F-B, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J (2013a): Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement 9:176-188.
12. Boxer AL, Knopman DS, Kaufer DI, Grossman M, Onyike C, Graf-Radford N, Mendez M, Kerwin D, Lerner A, Wu C-K, Koestler M, Shapira J, Sullivan K, Klepac K, Lipowski K, Ullah J, Fields S, Kramer JH, Merrilees J, Neuhaus J, Mesulam MM, Miller BL (2013b): Memantine in patients with frontotemporal lobar degeneration: A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 12:149-156.
13. Button KS, Ioannidis JPA, Mokrysz C, Nosek BA, Flint J, Robinson ESJ, Munafò MR (2013): Power failure: Why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365-376.
14. Chou Y-Y, Leporé N, Saharan P, Madsen SK, Hua X, Jack CR, Shaw LM, Trojanowski JQ, Weiner MW, Toga AW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (2010): Ventricular maps in 804 ADNI subjects: Correlations with CSF biomarkers and clinical decline. Neurobiol Aging 31:1386-1400.
15. Cook P, Bai Y, Nedjati-Gilani S (2006): Camino: Open-source diffusion-MRI reconstruction and processing. Presented at the 14th Scientific Meeting of the International Society for Magnetic Resonance Imaging in Medicine, Seattle, WA, p 2759.
16. Das SR, Avants BB, Grossman M, Gee JC (2009): Registration based cortical thickness measurement. Neuroimage 45:867-879.
17. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM (2008): Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage 41:1220-1227.
18. Dhillon P, Gee JC, Ungar LH, Avants B (2013): Anatomically-constrained PCA for image parcellation. Presented at the International Workshop on Pattern Recognition in Neuroimaging (PRNI), Philadelphia, PA, pp 25-28.
19. Du A-T, Schuff N, Kramer JH, Rosen HJ, Gorno-Tempini ML, Rankin K, Miller BL, Weiner MW (2007): Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130:1159-1166.
20. Galton CJ, Patterson K, Graham K, Lambon-Ralph MA, Williams G, Antoun N, Sahakian BJ, Hodges JR (2001): Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology 57:216-225.
21. Goldmann Gross R, McMillan C, Cook P, Grossman M (2012): Volumetric imaging of gray and white matter in corticobasal syndrome (P05.035). Neurology 78:P05.041.
22. Goñi J, Cervantes S, Arrondo G, Lamet I, Pastor P, Pastor MA (2013): Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment. J Alzheimers Dis 33:1009-1019.
23. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011): Classification of primary progressive aphasia and its variants. Neurology 76:1006-1014.
24. Harris JM, Gall C, Thompson JC, Richardson AMT, Neary D, Plessis, Du D, Pal P, Mann DMA, Snowden JS, Jones M (2013): Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia. Neurology 80:1881-1887.
25. Hassan A, Whitwell JL, Josephs KA (2011): The corticobasal syndrome-Alzheimer's disease conundrum. Expert Rev Neurother 11:1569-1578.
26. Hornberger M, Wong S, Tan R, Irish M, Piguet O, Kril J, Hodges JR, Halliday G (2012): In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease. Brain 135:3015-3025.
27. Hu WT, Rippon GW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Josephs KA (2009): Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 24:1375-1379.
28. Hu WT, McMillan C, Libon D, Leight S, Forman M, Lee VM-Y, Trojanowski JQ, Grossman M (2010): Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 75:595-602.
29. Irwin DJ, McMillan CT, Toledo JB, Arnold SE, Shaw LM, Wang L-S, Van Deerlin V, Lee VM-Y, Trojanowski JQ, Grossman M (2012): Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol 69:1018-1025.
30. Jones DK, Knösche TR, Turner R (2013): White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI. Neuroimage 73:239-254.
31. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW (2006): Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol 63:1632-1638.
32. Kerchner GA (2011): Ultra-high field 7T MRI: A new tool for studying Alzheimer's disease. J Alzheimers Dis 26 (Suppl 3):91-95.
33. Klauschen F, Goldman A, Barra V, Meyer-Lindenberg A, Lundervold A (2009): Evaluation of automated brain MR image segmentation and volumetry methods. Hum Brain Mapp 30:1310-1327.
34. Klein A, Ghosh SS, Avants B, Yeo BTT, Fischl B, Ardekani B, Gee JC, Mann JJ, Parsey RV (2010): Evaluation of volume-based and surface-based brain image registration methods. Neuroimage 51:214-220.
35. Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR, Ashburner J, Frackowiak RSJ (2008): Automatic classification of MR scans in Alzheimer's disease. Brain 131:681-689.
36. Knopman DS, Jack CR, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo ND (2009): Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology 72:1843-1849.
37. Kohannim O, Hua X, Hibar DP, Lee S, Chou Y-Y, Toga AW, Jack CR, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (2010): Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging 31:1429-1442.
38. Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, Huang EJ, Trojanowski JQ, Growdon ME, Jang JY, Sidhu M, See TM, Karydas AM, Gorno-Tempini ML, Boxer AL, Weiner MW, Geschwind MD, Rankin KP, Miller BL (2011): Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327-340.
39. Lindberg O, Walterfang M, Looi JCL, Malykhin N, Ostberg P, Zandbelt B, Styner M, Paniagua B, Velakoulis D, Orndahl E, Wahlund L-O (2012): Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. J Alzheimers Dis 30:355-365.
40. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996): Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47:1-9.
41. Looi JCL, Rajagopalan P, Walterfang M, Madsen SK, Thompson PM, Macfarlane MD, Ching C, Chua P, Velakoulis D (2012): Differential putaminal morphology in Huntington"s disease, frontotemporal dementia and Alzheimer"s disease. Aust N Z J Psychiatry 46:1145-1158.
42. Lu PH, Lee GJ, Shapira J, Jimenez E, Mather MJ, Thompson PM, Bartzokis G, Mendez MF (2014): Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease. J Alzheimers Dis 39:261-269.
43. Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJM, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DMA (2010): Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol 119:1-4.
44. McMillan CT, Brun C, Siddiqui S, Churgin M, Libon D, Yushkevich P, Zhang H, Boller A, Gee J, Grossman M (2012): White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration. Neurology 78:1761-1768.
45. McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M (2013a): Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology 80:132-138.
46. McMillan CT, Irwin DJ, Avants BB, Powers J, Cook PA, Toledo JB, McCarty Wood E, Van Deerlin VM, Lee VM-Y, Trojanowski JQ, Grossman M (2013b): White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 84:949-955.
47. McMillan CT, Toledo JB, Avants BB, Cook PA, Wood EM, Suh E, Irwin DJ, Powers J, Olm C, Elman L, McCluskey L, Schellenberg GD, Lee VM-Y, Trojanowski JQ, Van Deerlin VM, Grossman M (2014): Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration. Neurobiol Aging 35:1473-1482.
48. Mesulam M, Wicklund A, Johnson N, Rogalski E, Léger GC, Rademaker A, Weintraub S, Bigio EH (2008): Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63:709-719.
49. Moeller JR, Habeck CG (2006): Reciprocal benefits of mass-univariate and multivariate modeling in brain mapping: Applications to event-related functional MRI, H(2) (15)O-, and FDG-PET. Int J Biomed Imaging 2006:79862.
50. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Hua X, Toga AW, Jack CR, Schuff N, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative (2009): Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp 30:2766-2788.
51. Muñoz-Ruiz MÁ, Hartikainen P, Koikkalainen J, Wolz R, Julkunen V, Niskanen E, Herukka S-K, Kivipelto M, Vanninen R, Rueckert D, Liu Y, Lötjönen J, Soininen H (2012): Structural MRI in frontotemporal dementia: Comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry. PLoS One 7:e52531.
52. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011): Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study. Lancet Neurol 10:785-796.
53. Oishi K, Zilles K, Amunts K, Faria A, Jiang H, Li X, Akhter K, Hua K, Woods R, Toga AW, Pike GB, Rosa-Neto P, Evans A, Zhang J, Huang H, Miller MI, van Zijl PCM, Mazziotta J, Mori S (2008): Human brain white matter atlas: Identification and assignment of common anatomical structures in superficial white matter. Neuroimage 43:447-457.
54. Pelaez-Coca M, Bossa M, Olm C; Alzheimer's Disease Neuroimaging Initiative (ADNI) (2011): Discrimination of AD and normal subjects from MRI: Anatomical versus statistical regions. Neurosci Lett 487:113-117.
55. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, Allison SC, Halabi C, Kramer JH, Johnson JK, Weiner MW, Forman MS, Trojanowski JQ, Dearmond SJ, Miller BL, Rosen HJ (2007): Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 22:474-488.
56. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011): Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456-2477.
57. Salvador R, Peña A, Menon DK, Carpenter TA, Pickard JD, Bullmore ET (2005): Formal characterization and extension of the linearized diffusion tensor model. Hum Brain Mapp 24:144-155.
58. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD (2009): Neurodegenerative diseases target large-scale human brain networks. Neuron 62:42-52.
59. Seo EH, Lee DY, Lee J-M, Park J-S, Sohn BK, Lee DS, Choe YM, Woo JI (2013): Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease. PLoS One 8:e53922.
60. Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VM-Y, Shaw LM, Trojanowski JQ (2012): CSF biomarkers cutoffs: The importance of coincident neuropathological diseases. Acta Neuropathol 124:23-35.
61. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289.
62. Zhang Y, Schuff N, Du A-T, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW (2009): White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 132:2579-2592.
63. Zhang Y, Schuff N, Ching C, Tosun D, Zhan W, Nezamzadeh M, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW (2011): Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia. Int J Alzheimers Dis 2011:546871.
64. Zhang Y, Tartaglia MC, Schuff N, Chiang GC, Ching C, Rosen HJ, Gorno-Tempini ML, Miller BL, Weiner MW (2013): MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. J Alzheimers Dis 33:431-444.
65. Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, Kramer JH, Weiner M, Miller BL, Seeley WW (2010): Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 133:1352-1367.